How should C‑peptide be measured after a standardized mixed‑meal (≈500 kcal, 50 % carbohydrate) and what post‑meal levels indicate normal versus impaired insulin secretion?

C-Peptide Measurement After Meals

For post-meal C-peptide assessment, use a standardized mixed meal (≈500 kcal, 50% carbohydrate) with blood sampling every 30 minutes through 300 minutes; a 90-minute C-peptide ≥0.2 nmol/L (≈0.6 ng/mL) indicates preserved insulin secretion, while <0.2 nmol/L suggests severe insulin deficiency. 1, 2

Standardized Testing Protocol

Meal Composition and Patient Preparation

• Administer a mixed meal of approximately 500 kcal with 50% carbohydrate content after an overnight fast 1
• The meal should be similar to what typically triggers the patient's symptoms if evaluating reactive hypoglycemia 1
• Hold all non-essential medications before testing 1
• Ensure the patient has fasted for at least 8 hours without caloric intake 3

Sampling Schedule and Measurements

• Collect blood samples before meal ingestion and every 30 minutes through 300 minutes (5 hours total) 1
• Measure plasma glucose, insulin, C-peptide, and proinsulin at each time point 1
• Use laboratory-measured plasma glucose, not point-of-care meters, as meters are insufficient for diagnostic decisions 1, 3
• If the patient develops severe symptoms before 300 minutes, obtain samples for all analytes before administering treatment 1

Interpretation of Post-Meal C-Peptide Levels

Normal vs. Impaired Insulin Secretion Thresholds

90-Minute Stimulated C-Peptide (Primary Endpoint):

• ≥0.2 nmol/L (≈0.6 ng/mL) = significant endogenous insulin secretion present 2, 4
• <0.2 nmol/L (≈0.6 ng/mL) = severe insulin deficiency 2, 4
• This 90-minute threshold provides 98% sensitivity and 100% specificity for detecting clinically meaningful insulin secretion 2

Peak C-Peptide Value:

• Peak values show less overlapping between diabetic and non-diabetic groups (only 3.8% overlap) compared to basal values (30.8% overlap) 5
• Peak C-peptide is a more reliable discriminator than fasting levels for assessing β-cell function 5

2-Hour Post-Meal C-Peptide Index (CPI):

• CPI at 2 hours = (C-peptide at 2h ÷ glucose at 2h) × 100 6
• CPI ≥2.97 is associated with ability to withdraw from insulin therapy in type 2 diabetes 6
• CPI <1.93 predicts continued insulin dependence 6
• The 2-hour CPI is a better predictor than fasting CPI for endogenous insulin secretory capacity 6

Additional Diagnostic Thresholds for Specific Clinical Contexts

For Diabetes Classification:

• <0.2 nmol/L suggests type 1 diabetes 7, 8
• >0.6 nmol/L indicates type 2 diabetes or preserved β-cell function 7, 8

For Hypoglycemia Evaluation (when glucose <55 mg/dL):

• C-peptide ≥0.6 ng/mL (≥0.2 nmol/L) with insulin ≥3 µU/mL = inappropriate endogenous insulin secretion (insulinoma, nesidioblastosis, or autoimmune hypoglycemia) 9, 10, 11
• C-peptide <0.6 ng/mL** with **insulin >3 µU/mL = exogenous insulin administration 10
• This combination provides ≈100% sensitivity and specificity for detecting inappropriate insulin secretion 10

Timing Patterns and Clinical Significance

Response Kinetics

• Type 1 diabetics often show delayed C-peptide responses, with a significant number peaking at 120 minutes rather than earlier 5
• The biphasic insulin secretion pattern (first phase 3-5 minutes, second phase 60-120 minutes) is lost in type 2 diabetes and prediabetes 12
• Post-bariatric hypoglycemia typically occurs 2-4 hours after meals, distinguishing it from fasting hypoglycemia of insulinoma 11

Practical Alternatives When Standard Testing Is Not Feasible

Random Non-Fasting C-Peptide:

• Highly correlated with 90-minute stimulated C-peptide (r=0.91-0.96) 4
• Random C-peptide <200 pmol/L gives 100% sensitivity and 93% specificity for severe insulin deficiency 4
• Allows assessment at the point patients are seen for clinical care without requiring meal testing 4
• Accuracy improves when concurrent glucose is ≥8 mmol/L (≈144 mg/dL) 4

Fasting C-Peptide:

• Fasting C-peptide ≥0.07 nmol/L provides 100% sensitivity and 97% specificity for significant endogenous insulin secretion (defined as 90-min stimulated ≥0.2 nmol/L) 2
• Highly correlated with 90-minute stimulated values (r=0.97) 2
• Offers a practical alternative when meal testing cannot be performed 2

Critical Pitfalls and Special Considerations

Assay Standardization Issues

• Significant variability exists between C-peptide assays from different manufacturers despite most using the same WHO calibrator 13, 14
• Laboratories must validate cut-offs using their specific assay platform 10
• The lack of standardization limits broader clinical application of published thresholds 13
• Clinicians should interpret results using laboratory-specific reference ranges 3

Testing in Patients on Exogenous Insulin

• Insulin omission may not always be necessary during mixed meal testing 2
• Administering usual morning insulin causes only a 20% reduction in peak C-peptide but the 0.2 nmol/L threshold still correctly classifies 98% of patients 2
• Exogenous insulin does not cross-react with C-peptide assays 10

Conditions Requiring Modified Interpretation

• Renal insufficiency: standard thresholds are not applicable; use β-hydroxybutyrate and glucagon stimulation instead 10
• Hepatic insufficiency: thresholds have not been validated 10
• Post-partial pancreatectomy: interpret with caution as thresholds are not validated 10
• Insulin autoimmune syndrome: extremely high insulin (>100 µU/mL) with high C-peptide and positive insulin antibodies (>0.4 U/mL) 11

When to Measure Additional Analytes

• Send insulin, C-peptide, and proinsulin for analysis only when plasma glucose <60 mg/dL (3.3 mmol/L) during hypoglycemia evaluation 1
• Measure insulin antibodies when evaluating unexplained hypoglycemia to exclude autoimmune causes 10, 11
• Screen for sulfonylureas and glinides during documented hypoglycemia to exclude drug-induced causes 9, 11

Tests to Avoid

• Do not use oral glucose tolerance tests to evaluate postprandial hypoglycemia; mixed meal tests are preferred 9, 11
• Avoid relying on point-of-care glucose meters for diagnostic interpretation 1, 3